Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Migraine (Adult) Clinical Trials

A listing of Migraine (Adult) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (24) clinical trials

Migraine headaches are debilitating conditions which can interrupt your way of life. Wake Research Associates is enrolling volunteers in a study testing the effectiveness, tolerability and safety of an investigational medication. If you suffer from frequent migraine headaches, you may qualify.

Phase N/A

BHV-3000 versus placebo in Acute Migraine. The study will recruit male and female patients 18 years of age and older with at least a one-year history of migraines (with or without aura), consistent with a diagnosis according to the International Classification of Headache Disorders, including an age of onset prior ...

Phase

People with Acute Migraines are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

This study will evaluate the safety and tolerability of the following doses of AGN-241689: 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60 mg BID for the prevention of episodic migraine and will characterize the dose/response relationship.

Phase N/A

Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States

Phase

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Phase N/A

The primary purpose of this migraine study is to determine if the investigational medication, Rimegepan, is effective in comparison to placebo in the acute treatment of moderate to severe migraine headache. After an initial 3-28 day screening period, qualified study participants will enter an up to 45 day treatment period. ...

Phase

A research study is evaluating an investigational medication for migraines.

Phase N/A

There is preliminary evidence from the treatment-resistant subpopulation in the Phase 3 migraine studies that galcanezumab may be efficacious and well-tolerated in these patients. Study CGAW will include up to 6 months on galcanezumab (3 months of double-blind treatment and 3 months of open-label treatment).

Phase

A research study is evaluating an investigational medication for migraines.

Phase N/A